Nitroglycerin and Platelet aggregation inhibition - a phase IV clinical study of FDA data
Platelet aggregation inhibition is reported only by a few people who take Nitroglycerin.
The phase IV clinical study analyzes which people take Nitroglycerin and have Platelet aggregation inhibition. It is created by eHealthMe based on reports of 45,512 people who have side effects while taking Nitroglycerin from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
45,512 people reported to have side effects when taking Nitroglycerin.
Among them, 3 people (0.01%) have Platelet aggregation inhibition.
What is Nitroglycerin?
Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 45,755 Nitroglycerin users for its effectiveness, alternative drugs and more.
What is Platelet aggregation inhibition?
Platelet aggregation inhibition is found to be associated with 66 drugs and 26 conditions by eHealthMe.
Number of Nitroglycerin and Platelet aggregation inhibition reports submitted per year:
Gender of people who have Platelet aggregation inhibition when taking Nitroglycerin *:
- female: 0.0 %
- male: 100 %
Common drugs people take besides Nitroglycerin *:
- Zetia: 3 people, 100.00%
- Xanax: 3 people, 100.00%
- Starlix: 3 people, 100.00%
- Remeron: 3 people, 100.00%
- Proscar: 3 people, 100.00%
- Multaq: 3 people, 100.00%
- Levoxyl: 3 people, 100.00%
- Inspra: 3 people, 100.00%
- Flomax: 3 people, 100.00%
- Effient: 3 people, 100.00%
Common side effects people have besides Platelet aggregation inhibition *:
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 33.33%
- Ventricular Extrasystoles (premature cardiac contraction): 1 person, 33.33%
- In-Stent Coronary Artery Restenosis: 1 person, 33.33%
- Heart Attack: 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Nitroglycerin and have Platelet aggregation inhibition?Check whether Platelet aggregation inhibition is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Platelet aggregation inhibition and when was it recovered:
Expand to all the drugs that have ingredients of nitroglycerin:
Alternative drugs to, pros and cons of Nitroglycerin:
- Nitroglycerin (45,755 reports)
Common Nitroglycerin side effects:
Browse all side effects of Nitroglycerin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Platelet aggregation inhibition treatments and more:
- Platelet aggregation inhibition (1,267 reports)
COVID vaccines that are related to Platelet aggregation inhibition:
- Platelet aggregation inhibition in Moderna COVID Vaccine
- Platelet aggregation inhibition in Pfizer BioNTech Covid Vaccine
- Platelet aggregation inhibition in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Platelet aggregation inhibition:
- Platelet aggregation inhibition (66 drugs)
All the conditions that are associated with Platelet aggregation inhibition:
- Platelet aggregation inhibition (26 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitroglycerin) and Nitroglycerin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prazepam and Enalapril Maleate drug interaction - 22 seconds ago
- Excedrin and Drug Dependence - 35 seconds ago
- Oedema Aggravated and Headache - 39 seconds ago
- Dactinomycin and Adriamycin Pfs drug interaction - 41 seconds ago
- Xylocaine and Librium drug interaction - 45 seconds ago
- Vfend and Hydrocortisone drug interaction - a minute ago
- Fluocinonide and Nicotrol drug interaction - a minute ago
- Prograf and Ubiquinone drug interaction - a minute ago
- Effient and Truvada drug interaction - a minute ago
- Lasix and Pitting Oedema - a minute ago